Union Active Momentum Fund
The Scheme seeks to generate long-term capital appreciation by investing in stocks showing strong momentum. Momentum stocks are such that exhibit relatively superior price momentum based on the phenomenon that stocks which have performed well in the past relative to other stocks (winners) continue to perform well in the future, and stocks that have performed relatively poorly (losers) continue to perform poorly. The portfolio of stocks will be selected, weighted and rebalanced using proprietary screens.
Growthvine rating: 1/5 — ranked #168 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹10.05 (as of 2026-11-13) |
|---|
| AUM | ₹543 Cr |
|---|
| Expense ratio | 2.08% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Sanjay Bembalkar |
|---|
| Exit load | 1% for redemption within 1 year |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −26.76% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 80.1% of NIFTY Alpha 50's upside and 81.6% of its downside.
Market cap allocation
| Large cap | 2.9% |
|---|
| Mid cap | 12.0% |
|---|
| Small cap | 85.1% |
|---|
Concentration
| Top 5 holdings | 14.5% |
|---|
| Top 10 holdings | 27.2% |
|---|
| Total holdings | 40 |
|---|
Top holdings
- TREPS — 12.2%
- Ather Energy Limited — 3.2%
- Sona BLW Precision Forgings Limited — 3.0%
- Laurus Labs Limited — 2.9%
- Avalon Technologies Limited — 2.8%
- Ratnaveer Precision Engineering Limited — 2.7%
- Welspun Corp Limited — 2.7%
- Sansera Engineering Limited — 2.5%
- Divis Laboratories Ltd. — 2.5%
- Shilpa Medicare Ltd. — 2.5%
Top sectors
- Pharma & Biotech — 21.5%
- Industrial Products — 20.1%
- Cash — 12.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 16.7% | Q1 (Top) | #19 of 167 |
| 2025 | −15.0% | Q4 (Bottom) | #130 of 132 |